Nektar Therapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 4.30 M | $309.61 M | 4,155.15% | 17.40% |
| BVF INC/IL | 05/15/2026 | 2.56 M | $184.16 M | 64.12% | 10.35% |
| TWO SEAS CAPITAL LP | 05/15/2026 | 1.96 M | $140.96 M | 162.91% | 7.92% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.20 M | $86.13 M | 100.00% | 4.84% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 930.74 K | $66.97 M | 96.77% | 3.76% |
| PROSIGHT MANAGEMENT, LP | 05/15/2026 | 735.00 K | $52.88 M | 32.52% | 2.97% |
| BLACKROCK, INC. | 05/13/2026 | 692.65 K | $49.84 M | 7.29% | 2.80% |
| MORGAN STANLEY | 05/15/2026 | 659.39 K | $47.44 M | 16.41% | 2.67% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 578.00 K | $41.59 M | -3.02% | 2.34% |
| INVESCO LTD. | 05/12/2026 | 567.46 K | $40.83 M | 21.21% | 2.29% |
| CITADEL ADVISORS LLC | 05/15/2026 | 513.53 K | $36.95 M | 65.77% | 2.08% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 509.55 K | $36.66 M | 16.17% | 2.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 433.00 K | $31.15 M | 5.46% | 1.75% |
| WOODLINE PARTNERS LP | 05/15/2026 | 415.34 K | $29.88 M | 299.36% | 1.68% |
| LORD, ABBETT & CO. LLC | 05/14/2026 | 405.08 K | $29.15 M | 100.00% | 1.64% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 404.28 K | $29.09 M | -10.97% | 1.63% |
| EMERALD ADVISERS, LLC | 05/04/2026 | 394.60 K | $28.39 M | 2.67% | 1.60% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 390.68 K | $28.11 M | 20.61% | 1.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 346.80 K | $24.96 M | 36.34% | 1.40% |
| UBS GROUP AG | 05/05/2026 | 320.17 K | $23.04 M | 11.34% | 1.29% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 316.45 K | $22.77 M | 50.17% | 1.28% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 285.00 K | $20.51 M | 100.00% | 1.15% |
| 22NW, LP | 05/15/2026 | 281.12 K | $20.23 M | -15.10% | 1.14% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/11/2026 | 279.15 K | $20.08 M | -0.36% | 1.13% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 275.00 K | $19.79 M | 100.00% | 1.11% |
| GILDER GAGNON HOWE & CO LLC | 05/15/2026 | 271.76 K | $19.55 M | 30.46% | 1.10% |
| NEARWATER CAPITAL MARKETS, LTD | 05/15/2026 | 261.50 K | $18.81 M | 325.20% | 1.06% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 05/04/2026 | 256.11 K | $18.43 M | 1.18% | 1.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 249.09 K | $17.92 M | -35.02% | 1.01% |
| STATE STREET CORP | 05/15/2026 | 244.73 K | $17.61 M | 25.08% | 0.99% |
| JPMORGAN CHASE & CO | 05/13/2026 | 240.10 K | $15.67 M | 59.21% | 0.97% |
| BRAIDWELL LP | 05/15/2026 | 222.70 K | $16.02 M | 100.00% | 0.90% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 221.10 K | $15.91 M | -39.32% | 0.89% |
| PATIENT SQUARE CAPITAL LP | 05/15/2026 | 210.00 K | $15.11 M | 100.00% | 0.85% |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | 04/27/2026 | 202.50 K | $14.57 M | 100.00% | 0.82% |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | 04/27/2026 | 198.26 K | $14.26 M | 100.00% | 0.80% |
| QUINN OPPORTUNITY PARTNERS LLC | 05/15/2026 | 179.25 K | $12.90 M | 108.75% | 0.72% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 169.31 K | $12.18 M | 100.00% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 168.01 K | $12.09 M | 39.56% | 0.68% |
| AMERIPRISE FINANCIAL INC | 07/17/2026 | 136.73 K | $9.84 M | 100.00% | 0.67% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 165.18 K | $11.88 M | 120.24% | 0.67% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 161.25 K | $11.60 M | 123.86% | 0.65% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 150.00 K | $10.79 M | 100.00% | 0.61% |
| MARSHALL WACE, LLP | 05/15/2026 | 140.59 K | $10.12 M | 485.22% | 0.57% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 126.94 K | $9.13 M | -14.11% | 0.51% |
| 05/15/2026 | 126.40 K | $9.09 M | -31.86% | 0.51% | |
| SEVEN GRAND MANAGERS, LLC | 05/06/2026 | 125.00 K | $8.99 M | 100.00% | 0.51% |
| 05/15/2026 | 125.00 K | $8.99 M | 100.00% | 0.51% | |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 05/12/2026 | 122.33 K | $8.80 M | -34.97% | 0.49% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 121.54 K | $8.74 M | -42.21% | 0.49% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nektar Therapeutics institutional Ownership - FAQ's
During the previous two years, 356 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were:
EMERALD ADVISERS, LLC: 390,158
EMERALD MUTUAL FUND ADVISERS TRUST: 255,587
Bronte Capital Management Pty Ltd.: 198,434
APEIRON CAPITAL Ltd: 106,431
CITIGROUP INC: 102,760
Bank of New York Mellon Corp: 96,061
131.55% of Nektar Therapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 90.59 M shares in the last 24 months. This purchase volume represents approximately $6.26 B in transactions.